DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2006

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End

31/12/2006
Quarter3
Quarterly report for the financial period ended30/09/2006
The figureshave not been audited

Attachments

CCMDBIO-Q3 2006.xls
104 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2006

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2006
30/09/2005
30/09/2006
30/09/2005
RM'000
RM'000
RM'000
RM'000
1Revenue
26,218
22,710
81,125
71,402
2Profit/(loss) before tax
9,685
8,217
30,602
25,040
3Profit/(loss) for the period
7,367
5,960
22,738
17,530
4Profit/(loss) attributable to ordinary equity holders of the parent
7,367
5,960
22,738
17,530
5Basic earnings/(loss) per share (sen)
5.28
4.44
16.31
13.22
6Proposed/Declared dividend per share (sen)
0.00
0.00
7.00
0.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
1.0000
1.0100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameCCM DUOPHARMA BIOTECH BERHAD  
Stock Name CCMDBIO    
Date Announced22 Nov 2006  
CategoryFinancial Results
Reference NoCS-061120-42087